Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Despite the efficacy of continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnea (OSA), compliance with therapy remains suboptimal.The aim of this study was to determine whether the use of S9TM increased compliance in established CPAP users.
Methods: Subjects with OSA (50) were recruited into the study. When subjects entered the study, 28 days of respective compliance data were downloaded from the patient's usual CPAP device. Subjects trialled the S9 CPAP for 28 days.Subjects then resumed use of their usual CPAP for 28 days.Compliance data from the patient's usual CPAP pre- and post-trialling S9 were compared with data from the S9 CPAP.
Results: Patients were significantly more compliant when using the S9 than their usual CPAP device both pre- and post-S9 based on average daily usage. CPAP pre-S906.58±1.95(mean hours±SD), S907.08±1.18 h and CPAP post-S906.71±1.72 h. The difference between CPAP pre-S9 and S9 was 0.5 h (p00.003). The difference between S9 and CPAP post-S9 was 0.35 h (p00.01). There was no significant difference between CPAP pre-S9 and CPAP post-S9 (p00.34).Patients also completed questionnaires comparing the S9 system to their usual device. Subjective feedback showed a strong preference for the S9.
Conclusions: Participants were significantly more compliant when using the S9 than their usual CPAP device both pre and post-S9 use
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575556 | PMC |
| http://dx.doi.org/10.1007/s11325-012-0651-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardiovascular benefit of continuous positive airway pressure according to high-risk obstructive sleep apnoea: a multi-trial analysis.
Eur Heart J
August 2025
Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115, USA.
Background And Aims: Randomized trials of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnoea (OSA) in patients with cardiovascular disease have not detected reduced risk of major adverse cardiovascular and cerebrovascular events (MACCEs). This study tested whether the cardiovascular benefit of CPAP occurs preferentially in high-risk OSA, characterized by greater OSA-related heart rate acceleration or hypoxaemia.
Methods: In a post hoc analysis of pooled Randomized Intervention with Continuous Positive Airway Pressure in Coronary Artery Disease and Obstructive Sleep Apnoea, Impact of Continuous Positive Airway Pressure on Patients with Acute Coronary Syndrome and Nonsleepy Obstructive Sleep Apnoea, and Sleep Apnoea Cardiovascular Endpoints Study randomized trials; outcomes were stratified by high-risk OSA status, defined by heart rate response following OSA respiratory events >9.
Images: A disorder-specific CPAP compliance pattern.
J Clin Sleep Med
August 2025
Department of Pulmonology, Leuven University Center for Sleep and Wake Disorders (LUCS), University Hospitals Leuven, Leuven, Belgium.
A patient, previously diagnosed with moderate obstructive sleep apnea and treated with continuous positive airway pressure, was seen for her yearly routine follow-up. A CPAP compliance report of the previous year revealed a periodic usage with almost stable monthly fluctuation between proper and poor adherence. The patient declared compliant usage when sleeping.
View Article and Find Full Text PDFHealthy lifestyle factors and recurrent cardiovascular events in patients with OSA: the SAVE study.
BMC Med
July 2025
The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Missenden Road, PO Box M201, Sydney, NSW, 2050, Australia.
Background: The extent to which healthy lifestyle factors influence recurrent cardiovascular events in obstructive sleep apnea (OSA) patients is uncertain. To evaluate the association between adherence to baseline healthy lifestyle and the risk of recurrent cardiovascular events in OSA patients.
Methods: Post hoc analyses of the Sleep Apnea Cardiovascular Endpoints (SAVE) study involving participants with moderate-to-severe OSA and established cardiovascular disease (CVD) who were randomized to continuous positive airway pressure (CPAP) plus usual care or usual care alone.
Using short video-based educational intervention to enhance initial acceptance to continuous positive pressure therapy in Thai obstructive sleep apnea patients in a tertiary care: a randomized controlled trial.
Sleep Breath
July 2025
Siriraj Sleep Center, Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkoknoi, Bangkok, 10700, Thailand.
Purpose: Obstructive sleep apnea (OSA) is a prevalent condition associated with decreased quality of life and increased risk of cardiovascular complications. Continuous positive airway pressure (CPAP) therapy is the gold standard treatment, particularly in moderate to severe OSA. Its effectiveness depends on patient adherence, with compliance rates ranging from 46 to 83%.
View Article and Find Full Text PDFRespiratory distress in late-preterm neonates: from controversy to consensus - a survey of regional advisory boards and neonatologists in France.
BMJ Paediatr Open
June 2025
Chiesi SA France, Bois-Colombes, France.
Objective: Late-preterm neonates present with more complications at birth than full-term neonates. The care of these infants is sometimes controversial. Our study aims at examining the practices of French neonatologists and compares them to the literature.
View Article and Find Full Text PDF